| 中文名称: | AE-3763 一键复制产品信息 | ||||
|---|---|---|---|---|---|
| 英文名称: | AE-3763 | ||||
| 别名: | AE-3763 AE-3763 | ||||
| CAS No: | 291778-77-3 | 分子式: | C23H34F3N5O7 | 分子量: | 549.54 | 
| CAS No: | 291778-77-3 | ||||
| 分子式: | C23H34F3N5O7 | ||||
| 分子量: | 549.54 | ||||
基本信息
| 产品编号: | A12411 | ||||
| 产品名称: | AE-3763 | ||||
| CAS: | 291778-77-3 | 
 储存条件 | 粉末 | -20℃ | 四年 | 
| 
 | 
 | ||||
| 分子式: | 溶于液体 | -80℃ | 六个月 | ||
| 分子量 | 549.54 | -20℃ | 一个月 | ||
| 化学名: | |||||
| Solubility (25°C): | |||||
| 
 体外: 
 | DMSO | 15mg/mL (27.2956mM; Need ultrasonic) | |||
| Ethanol | 
 | ||||
| Water | 
 | ||||
| 体内(现配现用): | 1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility: ≥ 1.67mg/mL (3.04mM); Clear solution | ||||
| 此⽅案可获得 ≥ 1.67mg/mL (3.04mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 16.699999mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加 ⼊ 50μL Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 | |||||
| 2.请依序添加每种溶剂:10% DMSO→90% (20% SBE-β-CD in saline) Solubility: ≥ 1.67mg/mL (3.04mM); Clear solution | |||||
| 此⽅案可获得 ≥ 1.67mg/mL (3.04mM,饱和度未知) 的澄清溶液。以 1mL ⼯作液为例,取 100μL 16.699999mg/mL 的澄清 DMSO 储备液加到 900μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中,混合均匀。 | |||||
| 3.请依序添加每种溶剂:10% DMSO→90% corn oil Solubility: ≥ 1.67mg/mL (3.04mM); Clear solution | |||||
| 此⽅案可获得 ≥ 1.67mg/mL (3.04mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 16.699999mg/mL 的澄清 DMSO 储备液加到 900μL ⽟⽶油中,混合均匀。 | |||||
| <1mg/ml表示微溶或不溶。 | |||||
| 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 | |||||
| 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | |||||
制备储备液
| 
 浓度 
 溶液体积 质量 | 
 1mg | 
 5mg | 
 10mg | 
| 1mM | 1.8197mL | 9.0985mL | 18.1970mL | 
| 5mM | 0.3639mL | 1.8197mL | 3.6394mL | 
| 10mM | 0.1820mL | 0.9099mL | 1.8197mL | 
生物活性
| 产品描述 | 一种基于多肽的人中性粒细胞弹性蛋白酶 (human neutrophil elastase) 抑制剂。 | 
| 靶点 | IC50: 29nM (Human neutrophil elastase) | 
| 体外研究 | AE-3763 exhibits potent in vitro inhibitory activity against human neutrophil elastase as well as extremely high solubility and stability in water | 
| 体内研究 | Edema and leukocytes infiltration into the lung are significantly inhibited by infusion of AE-3763. AE3763 significantly improves survival rate by 24h in a mouse model of fatal shock associated with multiple organ dysfunction. AE-3763 dosedependently prevents hemorrhage when given intravenously by infusion (ED50: 0.42mg/kg/h) or by bolus injection (1.2mg/kg). With regard to the toxicity of AE-3763 in mice, the results of a preliminary study have shown no overt toxic effect even at the high dose of 300mg/kg, iv | 
推荐实验方法(仅供参考)
| Animal Administration | Mice D-Galactosamine shock is induced in C3H/HeN mice (6-7w, 22-25g). AE-3763 (10 or 100mg/kg) is administrated intraperitoneally six times at 2h interval. Control animals receive the vehicle (PBS) instead of AE-3763. Animal’s survival rate is observed up to 24 h after shock induction | 
                                    本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
                                    质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
                                
摩尔浓度计算公式
                                    用本工具协助配置特定浓度的溶液,使用的计算公式为:
                                    开始浓度 x 开始体积 = 最终浓度 x 最终体积
                                
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )
 
             
                     
                                 
                         
                         
                         
             
             
             
            